Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Raj Kumar, Keshaw Ram Aadil, Kunal Mondal, Yogendra Kumar Mishra, David Oupicky, Seeram Ramakrishna & Ajeet Kaushik. (2022) Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology. Critical Reviews in Biotechnology 42:8, pages 1180-1212.
Read now
Read now
Andrea Perrelli, Parisa Fatehbasharzad, Valerio Benedetti, Chiara Ferraris, Marco Fontanella, Elisa De Luca, Mauro Moglianetti, Luigi Battaglia & Saverio Francesco Retta. (2021) Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opinion on Drug Delivery 18:7, pages 849-876.
Read now
Read now
Chandrakantsing V. Pardeshi & Veena S Belgamwar. (2020) Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs. Materials Technology 35:5, pages 249-266.
Read now
Read now
Qingqing Meng, Aiping Wang, Hongchen Hua, Ying Jiang, Yiyun Wang, Hongjie Mu, Zimei Wu & Kaoxiang Sun. (2018) Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. International Journal of Nanomedicine 13, pages 705-718.
Read now
Read now
Luigi Battaglia, Pier Paolo Panciani, Elisabetta Muntoni, Maria Teresa Capucchio, Elena Biasibetti, Pasquale De Bonis, Silvia Mioletti, Marco Fontanella & Shankar Swaminathan. (2018) Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery. Expert Opinion on Drug Delivery 15:4, pages 369-378.
Read now
Read now
Chandrakantsing Vijaysing Pardeshi & Veena Shailendra Belgamwar. (2017) Ropinirole-dextran sulfate nanoplex for nasal administration against Parkinson’s disease: in silico molecular modeling and in vitro–ex vivo evaluation. Artificial Cells, Nanomedicine, and Biotechnology 45:3, pages 635-648.
Read now
Read now
Chenchen Bi, Aiping Wang, Yongchao Chu, Sha Liu, Hongjie Mu, Wanhui Liu, Zimei Wu, Kaoxiang Sun & Youxin Li. (2016) Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment. International Journal of Nanomedicine 11, pages 6547-6559.
Read now
Read now
Abhijeet D Kulkarni, Harun M Patel, Sanjay J Surana, Veena S Belgamwar & Chandrakantsing V Pardeshi. (2016) Brain–blood ratio: implications in brain drug delivery. Expert Opinion on Drug Delivery 13:1, pages 85-92.
Read now
Read now
Articles from other publishers (58)
Xiaomei Yao, Yichao Guan, Jianli Wang & Dong Wang. (2024) Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles. Heliyon 10:1, pages e21789.
Crossref
Crossref
Carlos Pintado-Grima, Oriol Bárcenas, Valentín Iglesias, Jaime Santos, Zoe Manglano-Artuñedo, Irantzu Pallarès, Michał Burdukiewicz & Salvador Ventura. (2023) aSynPEP-DB: a database of biogenic peptides for inhibiting α-synuclein aggregation. Database 2023.
Crossref
Crossref
Prajakta Teli, Vaijayanti Kale & Anuradha Vaidya. (2023) Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting. Cell and Tissue Research.
Crossref
Crossref
Radka Boyuklieva, Plamen Zagorchev & Bissera Pilicheva. (2023) Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies. Biomedicines 11:8, pages 2198.
Crossref
Crossref
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova & Jianqin Lu. (2023) Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
Christine Gander, Kejing Shi, Ali Nokhodchi & Matthew Lam. (2023) A Review of the Benefits 3D Printing Brings to Patients with Neurological Diseases. Pharmaceutics 15:3, pages 892.
Crossref
Crossref
Zi-Hua Guo, Saadullah Khattak, Mohd Ahmar Rauf, Mohammad Azam Ansari, Mohammad N. Alomary, Sufyan Razak, Chang-Yong Yang, Dong-Dong Wu & Xin-Ying Ji. (2023) Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders. Molecules 28:3, pages 1283.
Crossref
Crossref
Dipayan Roy, Anupama Modi, Ritwik Ghosh & Julián Benito-León. 2023. Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials. Antiviral and Antimicrobial Coatings Based on Functionalized Nanomaterials
447
484
.
Sagar Trivedi, Aditi Kamdar, Vidyadevi Bhoyar & Veena Belgamwar. 2023. Nanotechnology Principles in Drug Targeting and Diagnosis. Nanotechnology Principles in Drug Targeting and Diagnosis
353
393
.
Rania M. Hathout & Abdelkader A. Metwally. 2023. A Handbook of Artificial Intelligence in Drug Delivery. A Handbook of Artificial Intelligence in Drug Delivery
241
257
.
Namdev Dhas, Soji Neyyar, Atul Garkal, Ritu Kudarha, Jahanvi Patel, Srinivas Mutalik & Tejal Mehta. 2023. Nasal Drug Delivery. Nasal Drug Delivery
101
126
.
Rania M. Hathout & Eman M. El-Marakby. (2022) Meta-Analysis: A Convenient Tool for the Choice of Nose-to-Brain Nanocarriers. Bioengineering 9:11, pages 647.
Crossref
Crossref
Yong-Bo Zhang, Dong Xu, Lu Bai, Yan-Ming Zhou, Han Zhang & Yuan-Lu Cui. (2022) A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 14:9, pages 1974.
Crossref
Crossref
Nicolò Montegiove, Eleonora Calzoni, Carla Emiliani & Alessio Cesaretti. (2022) Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. Journal of Functional Biomaterials 13:3, pages 125.
Crossref
Crossref
Madhuri Sharon. 2022. Nanoparticles for Therapeutic Applications. Nanoparticles for Therapeutic Applications
303
328
.
Chhavi Bhalothia & Girima Nagda. (2022) Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 69, pages A1-A13.
Crossref
Crossref
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, Shadab Md, Nabil A. Alhakamy, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Mohammad Zaki Ahmad & Awanish Mishra. (2022) Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery. Biochemical Pharmacology 195, pages 114849.
Crossref
Crossref
Rahul Shukla, Vaibhavi Srivastava, Aakriti Sethi & Munindra Ruwali. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
243
259
.
Fakhara Sabir, Qurrat Ul Ain, Abbas Rahdar, Zhugen Yang, Mahmood Barani, Mauhammad Bilal & Nikhil Bhalla. 2022. Synthesis and Applications of Nanoparticles. Synthesis and Applications of Nanoparticles
455
485
.
Pallavi Kiran, Sujit Kumar Debnath, Suditi Neekhra, Vaishali Pawar, Amreen Khan, Faith Dias, Shubham Pallod & Rohit Srivastava. (2021) Designing nanoformulation for the nose‐to‐brain delivery in Parkinson's disease: Advancements and barrier. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Crossref
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Crossref
Yusuke Hatakawa, Akiko Tanaka, Tomoyuki Furubayashi, Rina Nakamura, Motomi Konishi, Toshifumi Akizawa & Toshiyasu Sakane. (2021) Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration. Pharmaceutics 13:10, pages 1673.
Crossref
Crossref
Sarah Jarrin, Abrar Hakami, Ben Newland & Eilís Dowd. (2021) Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems. Journal of Parkinson's Disease 11:s2, pages S229-S236.
Crossref
Crossref
Hetal P. Patel, Priyanshi A. Gandhi, Priyanka S. Chaudhari, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Furqan A. Maulvi & Bhavin A. Vyas. (2021) Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: Optimization and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 64, pages 102533.
Crossref
Crossref
Laura Deruyver, Clément Rigaut, Pierre Lambert, Benoît Haut & Jonathan Goole. (2021) The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Advanced Drug Delivery Reviews 175, pages 113826.
Crossref
Crossref
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Crossref
Amy Corbin Farr & May P. Xiong. (2020) Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage. Molecular Pharmaceutics 18:2, pages 593-609.
Crossref
Crossref
Abhijeet Kulkarni, Mahesh Shinde, Gaurav Sonawane, Hitesh Raotole, Rohit Pande & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
329
349
.
Rahul Shukla, Ashish Kumar & S.J.S. Flora. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
73
91
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Prashant G. Upadhaya, Sreeranjini Pulakkat & Vandana B. Patravale. (2020) Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Delivery and Translational Research 10:4, pages 1044-1056.
Crossref
Crossref
Bruno Fonseca-Santos, Patrícia Bento Silva, Roberta Balansin Rigon, Mariana Rillo Sato & Marlus Chorilli. (2020) Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Current Medicinal Chemistry 27:22, pages 3623-3656.
Crossref
Crossref
Kuldeep Rajpoot. (2020) Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines. Current Drug Targets 21:8, pages 819-836.
Crossref
Crossref
Bapi Gorain, Davinaa C. Rajeswary, Manisha Pandey, Prashant Kesharwani, Santosh A. Kumbhar & Hira Choudhury. (2020) Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. Current Pharmaceutical Design 26:19, pages 2233-2246.
Crossref
Crossref
Abuzer Alp Yetisgin, Sibel Cetinel, Merve Zuvin, Ali Kosar & Ozlem Kutlu. (2020) Therapeutic Nanoparticles and Their Targeted Delivery Applications. Molecules 25:9, pages 2193.
Crossref
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sunil Kumar Dubey, Anu Puri, Ravish J. Patel, Ajazuddin, V. Ravichandiran, Upadhyayula Suryanarayana Murty & Amit Alexander. (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Journal of Controlled Release 321, pages 372-415.
Crossref
Crossref
Ramin Ansari, Seyed Mahdi Sadati, Negin Mozafari, Hajar Ashrafi & Amir Azadi. (2020) Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders. European Polymer Journal 128, pages 109607.
Crossref
Crossref
Anoop V, Linda Ilene Cutinho, Paladugu Mourya, Amala Maxwell, Githa Thomas & Brijesh Singh Rajput. (2020) Approaches for encephalic drug delivery using nanomaterials: The current status. Brain Research Bulletin 155, pages 184-190.
Crossref
Crossref
Dharani Manickavasagam, Li Lin & Moses O. Oyewumi. (2020) Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation. Nanomedicine: Nanotechnology, Biology and Medicine 23, pages 102107.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
89
101
.
Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng & Xiaoping Yang. (2019) WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. ACS Chemical Neuroscience 10:12, pages 4787-4799.
Crossref
Crossref
Tingwang Guo, Yuanyuan Guo, Yuhua Gong, Jingou Ji, Shilei Hao, Jia Deng & Bochu Wang. (2019) An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage. International Journal of Pharmaceutics 566, pages 46-56.
Crossref
Crossref
Vedanti R. Salvi & Pravin Pawar. (2019) Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier. Journal of Drug Delivery Science and Technology 51, pages 255-267.
Crossref
Crossref
Neeraj Mishra, Sawarni Sharma, Rahul Deshmukh, Anoop Kumar & Ruchika Sharma. (2019) Development and Characterization of Nasal Delivery of Selegiline Hydrochloride Loaded Nanolipid Carriers for the Management of Parkinson’s Disease. Central Nervous System Agents in Medicinal Chemistry 19:1, pages 46-56.
Crossref
Crossref
Maliheh Ghadiri, Paul Young & Daniela Traini. (2019) Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics 11:3, pages 113.
Crossref
Crossref
Sally Vanden-Hehir, William Tipping, Martin Lee, Valerie Brunton, Anna Williams & Alison Hulme. (2019) Raman Imaging of Nanocarriers for Drug Delivery. Nanomaterials 9:3, pages 341.
Crossref
Crossref
Chandrakantsing V. Pardeshi, Veena S. Belgamwar & Sanjay J. Surana. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
163
175
.
Chandrakantsing V. Pardeshi & Veena S. Belgamwar. (2018) N,N,N‑trimethyl chitosan modified flaxseed oil based mucoadhesive neuronanoemulsions for direct nose to brain drug delivery. International Journal of Biological Macromolecules 120, pages 2560-2571.
Crossref
Crossref
Architha Aithal & P. S. Aithal. (2018) The Concept of Ideal Drug &its Realization Opportunity using Nanopharmaceutical Research Scenario. International Journal of Health Sciences and Pharmacy, pages 11-26.
Crossref
Crossref
Stella Gänger & Katharina Schindowski. (2018) Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa. Pharmaceutics 10:3, pages 116.
Crossref
Crossref
Daniel Hernandez-Baltazar, Rasajna Nadella, Maria de Jesus Rovirosa-Hernandez, Laura Mireya Zavala-Flores & Christian de Jesus Rosas Jarquin. 2018. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy. Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy.
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
Ioannis N. Mavridis, Maria Meliou, Efstratios-Stylianos Pyrgelis & Eleni Agapiou. 2018. Design of Nanostructures for Versatile Therapeutic Applications. Design of Nanostructures for Versatile Therapeutic Applications
1
29
.
Anujit Ghosal, Arti Vashist, Shivani Tiwari, Eram Sharmin, Sharif Ahmad & Jaydeep Bhattacharya. 2017. Advances in Personalized Nanotherapeutics. Advances in Personalized Nanotherapeutics
25
40
.
Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy & Elaine Del-Bel. (2016) Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotoxicity Research 30:4, pages 715-729.
Crossref
Crossref
Abhijeet D. Kulkarni, Yogesh H. Vanjari, Karan H. Sancheti, Harun M. Patel, Veena S. Belgamwar, Sanjay J. Surana & Chandrakantsing V. Pardeshi. (2016) New nasal nanocomplex self-assembled from charged biomacromolecules: N,N,N-Trimethyl chitosan and dextran sulfate. International Journal of Biological Macromolecules 88, pages 476-490.
Crossref
Crossref